COVID booster shots for certain U.S. adults after an advisory committee recommended an extra jab to help at-risk people increase their level of protection.
The health agency said that, according to its updated guidance, people should get a Pfizer-BioNTech COVID vaccine shot at least six months after their initial doses, even if they aren't immunocompromised, if: They are 65 or older or in long-term care settings; or they are aged between 50 and 64 and have underlying medical conditions., based on their individual risks. The same goes for people aged 18 to 64 who are at an increased risk of exposure to COVID because of where they work.
Actually the FDA didn't endorse it. Their advisory committee rejected it and were overruled due to political pressure
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older. I hope they approve the third shot for everyone! 'Outside advisors'? Like 'outside agitators'? 10 months into roll out & boosters already needed. Good thing I trust Pfizer's integrity.
Source: YahooNews - 🏆 380. / 59 Read more »
COVID-19 live updates: CDC advisory panel expected to vote on Pfizer booster within hoursThe CDC’s independent advisory panel is set to vote this afternoon on which Americans are eligible now for a Pfizer booster. Natural Immunity more effective than Vaccine?
Source: ABC - 🏆 471. / 51 Read more »
CDC advisory panel votes to recommend Pfizer boosters for people 65 and olderBREAKING: The CDC's independent advisory panel has unanimously voted to recommend booster doses of Pfizer's COVID vaccine for people aged 65 and older, along with long-term care facility residents, at least six months after their second dose. FilmTVDiversity get on it Moderna! My 8 months are approaching. That means I can get a booster Whoopi’s The vote was 3-16 last week but now it’s unanimous. No way.
Source: ABC - 🏆 471. / 51 Read more »
CDC panel recommends Pfizer boosters for high-risk individuals, people 65 and upA key panel at the Centers for Disease Control and Prevention on Thursday recommended the Pfizer-BioNTech coronavirus booster shots for people 65 years old and older, as well as those at high risk of severe COVID-19. Why it matters: The approval is the near-final step in making the booster shots available to tens of millions of Americans, and comes a day after the FDA approved Pfizer boosters for the two groups. CDC director Rochelle Walensky is expected to accept the recommendation.Stay on top
Source: YahooNews - 🏆 380. / 59 Read more »
CDC advisers sign off on Pfizer booster shot for certain groupsA CDC committee voted to recommend booster shots for people ages 65 and up, as well as certain individuals at high-risk for Covid-19. RIP The advisers voted that all people ages 65 and up and those in long-term care facilities who were initially vaccinated with Pfizer should receive a booster dose. People ages 50 to 64 with underlying medical conditions should also get a booster dose.
Source: NBCNews - 🏆 10. / 86 Read more »
CDC Panel Recommends Pfizer Covid-19 Boosters for Seniors, Certain Adults With Underlying Medical ConditionsA CDC panel recommended Pfizer Covid-19 boosters for seniors and some adults with underlying medical conditions, but not adults at high risk of exposure at work this makes no sense thanks 124th booster shot will save you according to WHO.
Source: WSJ - 🏆 98. / 63 Read more »